17-alpha-hydroxyprogesterone has been researched along with Cancer of Endometrium in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Almås, B; Bertelsen, BE; Fasmer, KE; Forsse, D; Haldorsen, IS; Halle, MK; Krakstad, C; Tangen, IL; Trovik, J; Viste, K | 1 |
| Aoki, I; Fujimoto, J; Tamaya, T | 1 |
| Fujimoto, S; Nomura, E; Sugawara, T | 1 |
| Bucciante, G; Maggino, T; Pirrone, F; Velluti, F | 1 |
| Arduino, S; Bellino, R; Febo, G; Lanza, A; Leo, L; Tessarolo, M; Wierdis, T | 1 |
| Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T | 1 |
| Brehme, U; Bruck, B; Finking, G; Gugel, N; Hanke, H; Hanke, S; Schmahl, FW; Wehrmann, M | 1 |
| Fujimoto, J; Hirose, R; Ichigo, S; Sakaguchi, H; Tamaya, T | 1 |
8 other study(ies) available for 17-alpha-hydroxyprogesterone and Cancer of Endometrium
| Article | Year |
|---|---|
Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Biomarkers, Tumor; Carcinoma, Endometrioid; Chromatography, Liquid; Cohort Studies; Cortodoxone; Endometrial Neoplasms; Estradiol; Estrogens; Estrone; Female; Gene Expression; Humans; Norway; RNA, Messenger; Signal Transduction; Tandem Mass Spectrometry | 2020 |
Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Immunoenzyme Techniques; Neovascularization, Physiologic; Oligonucleotides; Polymerase Chain Reaction; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroids; Thymidine Phosphorylase; Time Factors; Tumor Cells, Cultured | 2003 |
Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Aromatase; Carcinoma; Cell Line, Tumor; Cholesterol Side-Chain Cleavage Enzyme; Endometrial Neoplasms; Female; Gene Expression; Humans; Phosphoproteins; Pregnenolone; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Steroid 17-alpha-Hydroxylase; Transfection | 2004 |
The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Aged; Androgens; Body Mass Index; Body Weight; Breast Neoplasms; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Obesity; Pyrones; Regression Analysis; Risk Factors; Sex Hormone-Binding Globulin | 1993 |
Endometrial carcinoma in women 45 years of age or younger.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adult; Age Distribution; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Progesterone Congeners; Prognosis; Radiotherapy, Adjuvant; Survival Rate | 1996 |
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; DNA, Neoplasm; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Medroxyprogesterone Acetate; Neoplasm Proteins; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1996 |
Aortic plaque size and endometrial response in cholesterol-fed rabbits treated with estrogen plus continuous or sequential progestin.
Topics: 17-alpha-Hydroxyprogesterone; Animal Feed; Animals; Aorta; Aorta, Thoracic; Area Under Curve; Arteriosclerosis; Body Weight; Cholesterol; Disease Models, Animal; Drug Therapy, Combination; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Progestins; Rabbits; Triglycerides; Tunica Intima | 1999 |
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Blotting, Southern; Blotting, Western; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endothelial Growth Factors; Estradiol; Female; Humans; Hydrocortisone; Immunoenzyme Techniques; Lymphokines; Medroxyprogesterone Acetate; Progesterone; Progestins; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydrocortisol; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |